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Abstract
Background: The population of Nukufetau, a remote coral atoll island in Tuvalu in the Western
Pacific, received annual mass drug administration (MDA) of diethylcarbamazine and albendazole
under the Pacific Elimination of Lymphatic Filariasis program in 2001, 2002 and 2003, with the last
MDA occurring six months before a cross-sectional survey of the whole population for soil
transmitted helminths (STH).
Methods: A cross-sectional survey in May 2004 recruited 206 residents (35.2% of the population)
who provided a single faecal sample that was preserved, concentrated and examined
microscopically.
Results: Overall prevalence of STH was 69.9%; only hookworm and Trichuris trichiura were
diagnosed. Trichuris was present in 68.4% with intensity of infection being light in 56.3%, medium in
11.7% and heavy in 0.5%. Hookworm occurred in 11.7% with intensity of infection 11.2% being light
and medium in 0.5%. Twenty individuals (9.7%) had dual infections. The prevalence of Trichuris was
constant across all ages while the prevalence of hookworm was significantly lower in residents
below 30 years of age. In the age group 5–12 years comparison of results with a 2001 survey [1]
suggested that the prevalence of STH has declined minimally, due to sustained high prevalence of
Trichuris, while hookworm has declined dramatically from 34.4% to 1.6%.
Conclusion: The results of this survey suggest that although the MDA appears to have reduced
hookworm prevalence in residents below 30 years of age, there has been minimal effect on Trichuris
prevalence. An integrated program to control STH is required.
Background
Infections with soil transmitted helminths (STH) are com-
mon worldwide, with prevalence and parasite burden
being particularly high in developing countries among
school-aged children [2], although in many communities
the prevalence of hookworm is higher in adults than in
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mia, stunting, underweight and poor school performance
[4,5].
A survey of STH in 13 Pacific island countries and territo-
ries (PICT) in 2001–2 found a very narrow spectrum of
nematode parasites in children with a wide range of prev-
alences [1]. In this survey, prevalences in children aged 5
to 12 years ranged between 1% and 97% with prevalences
lower then 5% in Niue and the Cook Islands, but very
high prevalences (>80%) on the Marshall Islands, Kirib-
ati, and Tuvalu (Fig 1). The reasons for this variation are
not known.
In Tuvalu, samples from 118 children were analyzed, with
32 of these from the island of Nukufetau. Tuvalu had the
highest prevalence (97%) of the 13 PICT, and only hook-
worms and whipworms (Trichuris trichiura) were detected
[1]. There was not a single case of Ascaris infection. The
species of hookworm was not identified. Two schools
were surveyed, one on the main island of Funafuti with a
resident population of 4,452, and another on the remote
island of Nukufetau, with a resident population of 585.
Tuvalu had no programs or strategies to control STH
before 2001, but in 2001, after the faecal survey, annual
mass drug administration (MDA) of diethylcarbamazine
(DEC) and albendazole was commenced for lymphatic
filariasis elimination [6]. MDA was administered to all
residents aged two years and older except for pregnant
women and people considered too ill due to other dis-
eases. The coverage (number of residents who received
and consumed the drugs/total population) for Tuvalu was
81% in 2001, 47% in 2002 and 83% in 2003 [6].
This paper reports the results of a survey for STH amongst
all age groups of Nukufetau residents in 2004, three years
after the previous school-based survey [1] and following
three rounds of MDA using albendazole and DEC. The
survey was an opportunistic one, not linked to the MDA,
but initiated to establish the need for a STH control pro-
gram. The latest MDA had occurred six months prior to
this survey.
Methods
A cross-sectional survey was conducted on the island of
Nukufetau, Tuvalu. Nukufetau is located at S8°15'
E178°22', approximately 110 km north west of Funafuti,
the capital island of Tuvalu. At the time of the last census
in 2002, the island had 585 residents. All islands in
Tuvalu are coral atolls.
In May 2004, all residents of Nukufetau were provided
with containers for collection of faeces. To each specimen
returned, SAF (sodium acetate, acetic acid and formalde-
hyde) solution was added, approximately equal to the
volume of the faecal sample, and the faeces macerated to
form a slurry. The fixed samples were transported to Prin-
cess Margaret Hospital Laboratory (PMHL) on Funafuti
for examination. Details recorded for each sample were
the resident's name, age and gender.
At the PMHL approximately 0.2 g of faeces was placed in
a plastic conical 10 ml centrifuge tube with 8 ml of 10%
formalin and 1 ml of petrol, and vigorously shaken by
hand. The tubes were then centrifuged for 10 min at
roughly 500 G. The ring of petrol and associated debris
was loosened in each tube and all fluid in the tube tipped
out. Volume was then reconstituted to 1 ml using tap
water, mixed and 0.05 ml examined under two cover-slips
(24 × 24 mm) placed side by side on a microscope slide at
×100 magnification using a compound light microscope.
One slide was prepared from each specimen. Results were
reported as number of eggs seen per slide and then calcu-
lated as eggs per gram (EPG) by multiplying by 200. The
multiplication factor was determined by dilution of origi-
nal sample at fixation (×2), 0.2 g in test tube (×5), exami-
nation of 0.05 ml of 1 ml (×20). Egg results were reported
as light, medium and heavy using the criteria of WHO [7]:
an egg count of 1–999, 1000–9999 and ≥9999 EPG was
considered as light, moderate and heavy infection for T.
trichiura, and 1–1999, 2000–3999 and ≥3999 EPG as
light, moderate and heavy infection for hookworms.
Data was entered into an Excel file, checked for errors that
may have occurred during data entry and analysed using
Prevalences of soil transmitted nematodes in children aged 5–12 years in PICT in 2001–2 (data reanalysed from Hughes et al 2004 [1] table 4)Figur  1
Prevalences of soil transmitted nematodes in children aged 
5–12 years in PICT in 2001–2 (data reanalysed from Hughes 
et al 2004 [1] table 4).
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statistics. Chi-square tests were used to test for differences
in prevalence by gender and age category. Geometric
mean intensity of EPG for Trichuris was calculated for all
participants. The study was performed under James Cook
University Ethics Committee Approval number H1423
and with the permission and full involvement of the Min-
istry of Health, Tuvalu.
Results
Two hundred and six specimens were collected, 35.2% of
the population of Nukufetau. Males provided 96 speci-
mens (46.6%) and females 110 (53.4%). Mean age was
33 years with a median of 34 years and a range from seven
months to 84 years. All age-groups were represented
(Table 1) with 20–29 years under-represented at 11.8%
and >49 years over-represented at 60.5%. STH were diag-
nosed in 69.9%. (Table 1).
Only hookworm and Trichuris infections were diagnosed.
The overall prevalence of hookworm was 11.7% with a
prevalence of 2.1% in residents under 30 years of age and
19.6% amongst residents 30 years of age or older (Table
1). There was a significant difference in prevalence by age
category (p = .014). The overall prevalence of Trichuris was
68.4% with no significant difference in prevalence by age
group. Twenty (9.7%) residents had concomitant infec-
tions with hookworm and Trichuris, and only three were
infected by hookworm alone. There was no significant dif-
ference in prevalence of Trichuris or hookworm infections
by gender.
Amongst the 61 children aged 5–12 years, 46 (75.4%) had
STH, all with Trichuris and one (1.6%) had a concomitant
infection with hookworm. Fifty percent (12/24) of the
children less than 5 years had STH including 25% of the
12 children 2 years of age and younger. Only one child
under 5 years, a 4 year old, had hookworm infection. This
child also had Trichuris as did the remaining 12 STH pos-
itive children. The youngest child with Trichuris was 1 year
of age.
For individuals with Trichuris infection the mean (±std)
and maximum EPG were 673 (±1510) and 15,200 respec-
tively. The proportions with light, medium and heavy
infections were 56.3%, 11.7% and 0.5% respectively. For
hookworm the mean (±std) and maximum EPG were 242
(±407) and 2,040 respectively. The proportions with light
and medium infections were 11.2% and 0.5% respec-
tively. There were no heavy infections. For the 61 children
5–12 years of age surveyed, intensity of infection with Tri-
churis was light in 57.4%, medium in 16.4% and heavy in
1.6%.
Discussion
To the best of our knowledge, this is the first published
cross-sectional prevalence survey of STH amongst an
entire island population in the Western Pacific Region.
The prevalence of STH in this remote atoll island was high
(69.9%), mainly due to infection with T. trichiura, and the
spectrum of geohelminths was narrow. Trichuriasis was
equally distributed across all ages while the prevalence of
hookworm infection was low (2.1%) under 30 years of
age, but 19.6% in residents aged 30 years or older. Since
the species of hookworm in Tuvalu is unknown, the high
prevalence warrants studies to determine the species and
to evaluate the health impact of hookworm infection, par-
ticularly the possible occurrence of iron deficiency anae-
mia in reproductive age and older women. Interestingly,
not a single case of Ascaris infection was detected, con-
firming Hughes et al's findings for Tuvalu [1].
The only available baseline data on STH for the popula-
tion of Nukufetau prior to the MDA campaigns comes
from the survey amongst children aged 5–12 years in
2001 [1]. Although the prevalence of STH in this age range
has changed only slightly in Nukufetau since 2001, this is
due to the high prevalence of Trichuris. In the survey in
Table 1: Prevalence of STH in Nukutefau residents by age-group, 2004. Population data are from 2002 census.
Age group (years) Total population Number 
examined (% pop 
of age group)
Hookworm positive (%) Trichuris positive (%) STH positive (%) Trichuris 
Geometric Mean 
Intensity EPG*
0–9 171 62 (36.3) 1 (1.6) 43 (69.4) 43 (69.4) 54.2
10–19 95 26 (27.4) 1 (3.8) 19 (73.1) 19 (73.1) 67.6
20–29 51 6 (11.8) 0 (0.0) 5 (83.3) 5 (83.3) 40.9
30–39 70 15 (21.4) 3 (20.0) 10 (66.7) 10 (66.7) 35.3
40–49 79 25 (31.6) 5 (20.0) 16 (64.0) 17 (68.0) 17.6
50–59 52 37 (71.2) 9 (24.3) 27 (73.4) 27 (73.0) 56.0
60–69 47 23 (48.9) 3 (13.0) 13 (56.5) 14 (60.9) 20.3
≥70 20 12 (60.0) 2 (16.7) 8 (66.7) 9 (75.0) 35.5
Total 585 206 (35.2) 24 (11.7) 141 (68.4) 144 (69.9) 41.2
CI 0.95 9.5–13.9% 65.2–71.6% 66.7–73.1%
*Geometric Mean Intensity EPG calculated for all subjects as per Mani et al (2004).Page 3 of 6
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was 84% (n = 32) while in our survey prevalence was 75%
(n = 61), a decline in prevalence of 11%. However, hook-
worm has declined dramatically in this age-group from
34.4% to 1.6%, a 95% reduction in prevalence. Intensity
of infection with hookworm has remained constant with
all cases in the light category [1]. Intensity of Trichuris in
this age group has not changed significantly, with light
59.4% and medium 25% in 2001 and light 57.4%,
medium 16.4% and heavy 1.6% in this survey. However,
direct comparison is difficult since the participants in nei-
ther survey were randomly selected [8]. Only one of the
24 children under 5 years, a 4 year old, had hookworm, a
prevalence of 4.2% for children less than 5 years of age.
Children less than 3 years at the time of this survey had
not participated in any MDA round, while those aged 3, 4
and 5 years and older had possibly participated in one,
two and three MDA rounds respectively. The transmission
of hookworm may have decreased as a result of the annual
MDA campaigns.
MDA with DEC and albendazole achieved a reduction in
hookworm prevalence in Indonesia from 25.3% to 5.9%
[3]. Although on Nukufetau the hookworm prevalence in
adults was high, without a pre-MDA baseline amongst
adults comments on trends cannot be made. The initial
hookworm prevalence was 50% in Indonesian residents
older than 50 years and demonstrated a dramatic reduc-
tion in this age group after two rounds of MDA [3]. A sin-
gle dose of 400 mg albendazole achieved an average cure
rate of 78% in 68 studies [9]. Hence, for Nukufetau after
albendazole had been administered annually for three
years, a lower prevalence would have been expected.
The coverage of MDA in Nukufetau, at least in the first and
third round, was very good. However, compliance with
the MDA may have affected the success of treatment, espe-
cially in the middle and older age groups, which showed
higher prevalences of hookworm infection. Unfortu-
nately, individual data on compliance was not available.
However, at the mass treatment rounds, men were more
likely to be unavailable for observed treatment owing to
their being absent while fishing or travelling.
Rate of re-infection after treatment can be considerable
[10], but the low prevalence of hookworm in children
suggests that incidence is low and that re-infection is
unlikely to account for the high adult prevalence. Trichuris
eggs can survive for extended times in the environment as
compared to hookworm eggs and larvae, which may have
contributed to a higher prevalence of trichuriasis than
hookworm infection after mass treatment. Additionally,
hookworm may have developed resistance to albenda-
zole. However, resistance of human hookworms to
anthelmintics has not been definitely reported. Resistance
to pyrantel was suspected in Australia in Ancylostoma duo-
denale with the strain susceptible to albendazole [11].
Reduced efficacy of mebendazole was reported in Mali
[12] and after 5 years of intensive therapy in Zanzibar
[13]. Although anthelmintic resistance is less likely to
account for persistence of hookworm than non-compli-
ance in MDA, standardised resistance testing should be
conducted on this population of hookworms in Nukufe-
tau [14,15].
This study highlights the persistence of Trichuris infection
after three rounds of MDA using albendazole and DEC.
Studies from Haiti, India and Sri Lanka reported in con-
trast to our data reduction of the prevalence of trichuriasis
after mass treatment with albendazole and DEC [16-18].
DEC has no significant activity against hookworm and
Ascaris lumbricoides [19] and is unlikely to be active against
T. trichiura. Albendazole has limited activity against Tri-
churis with prevalences after the standard single dose of
400 mg declining between 23% to 48% [9,20,21] or
showing no effect at all [10]. The prevalence of Trichuris
was reduced between 7% and 48%, the latter from a
cohort study, of Trichuris in Indonesia after two rounds of
MDA using albendazole and DEC [3]. A cure rate of 30%
with the same anthelminthic combination against T.
trichiura was reported in Sri Lanka [22]. Ongoing trans-
mission despite repeated MDA campaigns in Nukufetau is
suggested by the high rate (66%) of Trichuris in children
under 5 years of age. Another anthelminthic, such as
mebendazole or ivermectin, which has greater efficacy
against Trichuris than albendazole should be used in
Tuvalu to eliminate Trichuris. Mebendazole has been
reported to have a high efficacy against Trichuris infections
[23]. The data on efficacy of single dose ivermectin for T.
trichiura are inconsistent with cure rates ranging from 0%
to 88% [24-28], and two doses of ivermectin showed cure
rates between 84% and 100% [29,30]. Ivermectin with
albendazole had a higher cure rate than albendazole
alone (79% versus 30% respectively) [22].
The PICT share particular epidemiologic and ecological
features that may have contributed to these different
results. For example, the parasite fauna is different from
other parts of the world, which is exemplified by the com-
plete absence of ascariasis and the high prevalence of tri-
churiasis in our study population. Different strains with
different susceptibilities to anthelmintic drugs may also
prevail.
For Nukufetau chemotherapy should be combined with
an integrated control strategy to reduce the contamination
of the island with eggs [5]. Behaviours that lead to eggs
gaining access to soil and surviving the two weeks
required for development in the egg have not been inves-
tigated in PICT. Homes on Nukufetau have septic sewagePage 4 of 6
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only available source of potable water and when rainwa-
ter tanks become depleted during the dry season, residents
may be reluctant to use water for toilets and personal
hygiene (TN, personal observation). An association
between inadequate water supplies in schools and STH
was found in 14 PICT [1]. Defecation on the beach or in
the sea is not uncommon in Nukufetau (TN, personal
observation). The survival of hookworm eggs and larvae
and T. trichiura eggs in sea-water appear not to have been
tested. Experimentally sodium chloride at 2% concentra-
tion and higher had a deleterious effect on development
of hookworm eggs and larvae [31]; seawater contains
approximately 3.5% sodium chloride. However, the
embryo of Trichuris, protected by a thick shell, could
potentially survive immersion in sea-water. This hypothe-
sis warrants investigation as it has implications for man-
agement strategies for Trichuris in small island nations.
Conclusion
We have shown that on a remote island in the Western
Pacific the spectrum of STH present in the general popu-
lation is quite narrow with only hookworm and Trichuris
infections present and that the prevalence of STH remains
high after three rounds of MDA with albendazole and
DEC. It appears that the MDA for lymphatic filariasis
elimination has resulted in a significant reduction in
hookworm prevalence in residents under 30 years of age.
However, we assume based on previous data in children
aged 5–12 years [1] and the high prevalence overall that
annual community DEC and albendazole administration
has had a minimal effect on T. trichiura prevalence. Alter-
native anthelmintics plus measures to reduce environ-
mental contamination with helminth eggs need to be
considered as part of an integrated STH control program.
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